TECX
TECX
NASDAQ · Biotechnology

Tectonic Therapeutic Inc

$19.05
-0.73 (-3.69%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +95.4% upside
Low Target $31.47
Average Target $37.23
High Target $57.92
Current Price $19.05
Current
$19.05
Target
$37.23
$31.47 $37.23 avg $57.92
Scenario Analysis
Bear Case
$31.47
65.2%
Low target
Base Case
$37.23
+95.4%
Avg target
Bull Case
$57.92
+204.0%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$39.53
-51.8% from high
52-Week Low
$15.52
+22.7% from low
Target vs 52W High
$37.23
-5.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -10.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +116.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 35% $149.45 -38.1%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -60.7%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -35.8%